C
Chris Smith
Guest
- The company that made the experimental drug that President Trump received for his COVID-19 treatment last week is now seeking emergency use authorization.
- If the FDA grants the request, the US government will make the doses available for free under the current agreement.
- Regeneron said it has doses of its REGN-COV2 monoclonal antibody drug combo ready for nearly 50,000 patients.
Last week, President Trump confirmed he tested positive for COVID-19 after one of his closest aides showed symptoms and tested positive herself. He was given a ****tail of drugs that included remdesivir and dexamethasone, both of which were said to be effective against the novel coronavirus earlier this year.
But Trump also had access to a therapy not approved for widespread use, as it’s still in clinical trials. This happened just a few days after the company announced positive conclusions for one of its clinical trials. And now, that company is seeking emergency use authorization (EUA) from the Food and Drug Administration (FDA).
Continue reading...
Today's Top Deals
- iHealth’s ‘iPhone of thermometers’ just fell to 2020’s lowest price at Amazon
- 10 incredible Prime Day deals that just got here a week early
- 10 early Prime Day 2020 deals that’ll blow you away
Trending Right Now:
- Experts just gave us a deeply depressing new coronavirus warning
- If you take this common medication, call your doctor and throw it out
- Please read Dr. Fauci’s latest warning about the coronavirus right now
The experimental coronavirus drug that Trump took awaits FDA approval originally appeared on BGR.com on Thu, 8 Oct 2020 at 20:06:18 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report